Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Wnt-Frizzled (Fzd) signaling is crucial in carcinoma pathophysiology.
• Its specific role in human breast cancer remains unclear.
• The adaptor protein NHERF1 (Na+/H+ exchange regulatory factor 1) is abundant in normal mammary epithelium.

Purpose of the Study:

• To investigate the role of NHERF1 in regulating Wnt signaling in breast tissue.
• To determine NHERF1's impact on breast cancer cell proliferation and pathogenesis.

Main Methods:

• Investigated NHERF1 interactions with Fzd receptors using its PDZ domains.
• Assessed Wnt signaling and proliferation in NHERF1-deficient breast cancer cell lines.
• Analyzed mammary glands from NHERF1-knockout mice.
• Correlated NHERF1 expression with nuclear beta-catenin in human breast carcinomas.

Main Results:

• NHERF1 directly interacts with Fzd receptors via its PDZ domains, regulating beta-catenin activation.
• Loss of NHERF1 enhances canonical Wnt signaling and Wnt-dependent cell proliferation in vitro.
• NHERF1-knockout mouse mammary glands show increased duct density, proliferation, and beta-catenin activity.
• Human breast carcinomas exhibit an inverse correlation between NHERF1 expression and nuclear beta-catenin levels.

Conclusions:

• NHERF1 acts as a negative regulator of Wnt signaling in normal and neoplastic breast tissues.
• NHERF1 deficiency promotes breast tumor pathogenesis by increasing Wnt/beta-catenin signaling.
• NHERF1 is identified as a significant factor in the development of breast tumors.